Authors

1 isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Biology, University of Putra Malaysia, Malaysia

3 Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

4 Department of Health and Social Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Objective: Methadone poisoning can occur accidentally or intentionally for suicide or 
homicide purposes. The aim of this study was to evaluate the epidemiological and clinical 
manifestations of Methadone poisoning.
Methods: A descriptive analytical study was performed from 2010 to 2012 in the poisoning 
emergency and clinical toxicology departments of Noor hospital affiliated with Isfahan 
University of Medical Sciences (Isfahan, Iran). All patients with Methadone poisoning within 
this period of time were investigated. Different variables were recorded in a checklist.
Findings: A total of 385 patients were studied. About 85.7% had ingested only Methadone 
and 14.3% had ingested other medications with Methadone. Mean ± standard deviation 
of the age was 32.1 ± 15 years (range: 1‑90). Most of the patients were male (76.4%). 
Nearly 40% of the patients were narcotic addicts, 25.5% were addicts under surveillance of 
Methadone maintenance therapy centers and 34.5% were non‑addicts. Intentional poisoning 
was observed in most of the patients (57.7%). Most of the patients had a low level of 
consciousness on admission (58.2%). Respiratory depression and hypotension was observed 
in 35.6% and 12.7% of the cases as the most common symptoms. Regarding vital signs, there 
was a significant difference in respiratory rate on admission among different evaluated 
groups (P = 0.02). Length of hospital stay was 18.79 ± 0.72 h (range: 4‑240 h, median: 15 h). 
About 57 patients (25.8%) from the intentionally poisoned patients and 19 patients (12.3%) 
from the unintentionally poisoned patients had a history of psychiatric disorder (P = 0.001). 
Most of the patients survived without complications.
Conclusion: Addiction, age, gender, attempt to suicide and a history of psychiatric disorder 
were of the most important factors effective in Methadone poisoning, which should be 
considered in the public training and prevention of poisoning.

Keywords

1. Shartz M. Opiate and Narcotics: Clinical Management 
of Poisoning and Overdose. Philadelphia: WB Saunders 
Company; 1998. p. 505‑19.
2. LoVecchio F, Pizon A, Riley B, Sami A, D’Incognito C. Onset 
of symptoms after methadone overdose. Am J Emerg Med 
2007;25:57‑9.
3. Wolff K. Characterization of methadone overdose: Clinical 
considerations and the scientific evidence. Ther Drug Monit 
2002;24:457‑70.
4. Hsu WY, Chiu NY, Liao YC. Rhabdomyolysis and brain 
ischemic stroke in a heroin‑dependent male under methadone 
maintenance therapy. Acta Psychiatr Scand 2009;120:76‑9.
5. Roland EH, Lockitch G, Dunn HG, Peacock D, Pirie GE. 
Methadone poisoning due to accidental contamination of 
prescribed medication. Can Med Assoc J 1984;131:1357‑8.
6. Caplehorn JR, Drummer OH. Fatal methadone toxicity: Signs 
and circumstances, and the role of benzodiazepines. Aust N 
Z J Public Health 2002;26:358‑62.
7. Centers for Disease Control and Prevention (CDC). Overdose 
deaths involving prescription opioids among medicaid 
enrollees‑Washington, 2004‑2007. MMWR Morb Mortal Wkly 
Rep 2009;58:1171‑5.
8. Hon KL, Ho JK, Hung EC, Cheung KL, Ng PC. Poisoning 
necessitating pediatric ICU admissions: Size of pupils does 
matter. J Natl Med Assoc 2008;100:952‑6.
9. Clausen T, Anchersen K, Waal H. Mortality prior to, during 
and after opioid maintenance treatment (OMT): A national 
prospective cross‑registry study. Drug Alcohol Depend 
2008;94:151‑7.
10. Caplehorn JR. Deaths in the first two weeks of maintenance 
treatment in NSW in 1994: Identifying cases of iatrogenic 
methadone toxicity. Drug Alcohol Rev 1998;17:9‑17.
11. Afshari R, Maxwell SR, Bateman DN. Hemodynamic 
effects of methadone and dihydrocodeine in overdose. Clin 
Toxicol (Phila) 2007;45:763‑72.
12. Pilgrim JL, McDonough M, Drummer OH. A review of 
methadone deaths between 2001 and 2005 in Victoria, 
Australia. Forensic Sci Int 2013;226:216‑22.
13. Mégarbane B, Buisine A, Jacobs F, Résière D, Chevillard L, 
Vicaut E, et al. Prospective comparative assessment of 
buprenorphine overdose with heroin and methadone: Clinical 
characteristics and response to antidotal treatment. J Subst 
Abuse Treat 2010;38:403‑7.
14. Brands B, Blake J, Marsh DC, Sproule B, Jeyapalan R, Li S. The 
impact of benzodiazepine use on methadone maintenance 
treatment outcomes. J Addict Dis 2008;27:37‑48.
15. McCowan C, Kidd B, Fahey T. Factors associated with 
mortality in Scottish patients receiving methadone in primary 
care: Retrospective cohort study. BMJ 2009;338:b2225.
16. Bernard JP, Havnes I, Slørdal L, Waal H, Mørland J, 
Khiabani HZ. Methadone‑related deaths in Norway. Forensic 
Sci Int 2013;224:111‑6.